- ICH GCP
- Registro de ensaios clínicos dos EUA
- Ensaio Clínico NCT04733911
Recovery Kinetics Following Eccentric Exercise
Recovery Kinetics Following Three Exercise-induced Muscle Damage Protocols in Adult Males
Visão geral do estudo
Status
Condições
Intervenção / Tratamento
Descrição detalhada
It is known that eccentric exercise induces muscle microtrauma. Also, eccentric type of exercise are associated with inflammatory response. The leukocytes and the immune cells during the phagocytosis process alter the redox status causing secondary muscle damage to the muscle tissue and also increase oxidative stress concentration. Despite of the existence of studies that examine the muscle damage indicators, inflammatory response, performance and neuromuscular fatigue and oxidative stress concentrations after eccentric exercise, however no studies are detected in order to compare the differences among three eccentric protocols. The eccentric protocols will be differentiated in training volume and specifically in the eccentric repetitions in isokinetic dynamometer. Specifically, a randomized, fourth-trial, cross-over, repeated measures design will be applied. Healthy male adults (age 18-30 years) will participate in the present study. Also, it is considered necessary that the participants will not suffer from any musculoskeletal injuries that will limit their ability to perform the exercise protocols. Also the participants will not be smokers and will not consume alcohol and nutritional supplements.
In the first phase all participants will sign an informed consent form after they will be informed about all benefits and risks of this study and they will sign a recent historical of musculoskeletal injury or illness form. Subsequently, fasting blood samples will be collected by venipuncture using a disposable needle (20-gauge) in order to measure muscle damage markers (CK), inflammation markers (WBC) and oxidative stress markers (TBARS, PC, GSH, ΤΑC, CAT, UA). After, delayed onset muscle soreness (DOMS) in the knee flexors (KF) and extensors (KE) of both limbs, body weight (BW), height and body composition (DXA method) will be measured in the lab. Completing the first phase, participants will be instructed by a dietitian how to record a 5 days diet recalls estimating the energy intake during the trials will be the same. The knee range of motion (KJRM) will be determined by the use of a goniometer, 24 hours after (second phase). The counter movement jump (CMJ) will be evaluated on a force platform using two force platforms at 1000 Hz, with each foot in parallel on the two platforms providing a separate yet time-synchronized measurement of the data for each leg. During the CMJ will be measured the jump height (cm), the ground reaction force (N), the peak and mean power (W/kg), the vertical stiffness (Kvert, N/m/kg) and the peak rate of force development (RFD, N/s), while at the same time will be evaluated the change in peak and mean normalized EMG during the eccentric and concentric phases of the counter movement jump, for the vastus medialis (VM) and vastus lateralis muscles. Electromyography data will be collected wirelessly at 2.000 Hz using a Myon MA-320 EMG system. The peak eccentric and concentric isokinetic torque of the knee flexors and extensors, in both limbs will be evaluated on an isokinetic dynamometer at 60°/sec. Also, the isometric peak torque of the knee extensors will be evaluated at 65° in both limbs. Finally, Open-circuit spirometry will be utilized for assessment of maximal oxygen consumption (VO2max) using an automated online pulmonary gas exchange system via breath-by-breath analysis during a graded exercise testing on a treadmill.
96 hours after, the participants are going to perform one of the three eccentric protocols randomly, on an isokinetic dynamometer. The eccentric protocol will be performed on a different limb for each trial. The ECC 75 trial will include 75 eccentric maximum repetitions (5 sets, 15 reps/set and recovery period: 30sec.) at 60°/sec. The ECC 150 trial will include 150 eccentric maximum repetitions (10 sets, 15 reps/set and recovery period: 30sec.) at 60°/sec. The ECC 300 trial will include 300 eccentric maximum repetitions (20 sets, 15 reps/set and recovery period: 30sec.) at 60°/sec. The DOMS indicator in the knee flexors (KF) and extensors (KE) of both limbs and the KJRM will be evaluated immediately after each protocol. Also, the (CMJ) will be evaluated on a force platform using two force platforms at 1000 Hz, with each foot in parallel on the two platforms providing a separate yet time-synchronized measurement of the data for each leg. During the CMJ will be measured the jump height (cm), the ground reaction force (N), the peak and mean power (W/kg), the vertical stiffness (Kvert, N/m/kg) and the peak rate of force development (RFD, N/s), while at the same time will be evaluated the change in peak and mean normalized EMG during the eccentric and concentric phases of the counter movement jump, for the vastus medialis (VM) and vastus lateralis muscles. Electromyography data will be collected wirelessly at 2.000 Hz using a Myon MA-320 EMG system. In addition, the peak eccentric and concentric isokinetic torque of the knee flexors and extensors, in both limbs will be evaluated on an isokinetic dynamometer at 60o/sec. Also, the isometric peak torque of the knee extensors will be evaluated at 65o in both limbs. All the above markers will be evaluated 24, 48 and 192 hours post eccentric protocol, however at these time points, fasting blood samples (20ml) will be collected in order to estimate hematological and biochemical indicators. Α 2 - week washout period will be adapted among trials. After, the participants will perform the process until they complete the trials.
Tipo de estudo
Inscrição (Real)
Estágio
- Não aplicável
Contactos e Locais
Locais de estudo
-
-
-
Tríkala, Grécia, 42100
- University o Thessaly, School of Physical Education and Sports Science
-
-
Critérios de participação
Critérios de elegibilidade
Idades elegíveis para estudo
Aceita Voluntários Saudáveis
Gêneros Elegíveis para o Estudo
Descrição
Inclusion Criteria:
- Aged between 18 and 30 years
- Body Mass Index between 18.5-24.9 kg/m*m
- Free of chronic diseases
- Free of musculoskeletal injury
- participants should be non-smokers
Exclusion Criteria:
- Musculoskeletal injury
- Chronic disease
- Use of alcohol, caffeine and any type of nutritional supplements or medication before (≥ 6 months) and throughout the study.
Plano de estudo
Como o estudo é projetado?
Detalhes do projeto
- Finalidade Principal: Ciência básica
- Alocação: Randomizado
- Modelo Intervencional: Atribuição cruzada
- Mascaramento: Nenhum (rótulo aberto)
Armas e Intervenções
Grupo de Participantes / Braço |
Intervenção / Tratamento |
|---|---|
|
Sem intervenção: Ao controle
Os participantes neste braço não receberão nenhuma intervenção.
|
|
|
Experimental: Eccentric 75
Participants in this arm will perform an eccentric exercise protocol consisted of 75 eccentric repetetions on an isokinetic dynamometer.
|
An acute bout of eccentric exercise will be performed on an isokinetic dynamometer, including 5 sets of 15 repetitions, with 30 sec rest intervals,at 60 degrees/sec.
|
|
Experimental: Eccentric 150
Participants in this arm will perform an eccentric exercise protocol consisted of 150 eccentric repetetions on an isokinetic dynamometer.
|
An acute bout of eccentric exercise will be performed on an isokinetic dynamometer, including 10 sets of 15 repetitions, with 30 sec rest intervals,at 60 degrees/sec.
|
|
Experimental: Eccentric 300
Participants in this arm will perform an eccentric exercise protocol consisted of 300 eccentric repetetions on an isokinetic dynamometer.
|
An acute bout of eccentric exercise will be performed on an isokinetic dynamometer, including 20 sets of 15 repetitions, with 30 sec rest intervals,at 60 degrees/sec.
|
O que o estudo está medindo?
Medidas de resultados primários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Change in white blood cell count
Prazo: At baseline, at 24, 48 and 192 hours following the eccentric exercise protocol.
|
White blood cell count will be measured using an automatic blood analyzer
|
At baseline, at 24, 48 and 192 hours following the eccentric exercise protocol.
|
|
Change in catalase activity
Prazo: At baseline, at 24, 48 and 192 hours following the eccentric exercise protocol.
|
Concentration of catalase will be measured in red blood cells
|
At baseline, at 24, 48 and 192 hours following the eccentric exercise protocol.
|
|
Change in uric acid in plasma
Prazo: At baseline, at 24, 48 and 192 hours following the eccentric exercise protocol.
|
concentration of uric acid will be measured in plasma
|
At baseline, at 24, 48 and 192 hours following the eccentric exercise protocol.
|
|
Change in protein carbonyls in blood
Prazo: At baseline, at 24, 48 and 192 hours following the eccentric exercise protocol.
|
Concentration of protein carbonyls will be measured in red blood cells
|
At baseline, at 24, 48 and 192 hours following the eccentric exercise protocol.
|
|
Change in total antioxidant capacity
Prazo: At baseline, at 24, 48 and 192 hours following the eccentric exercise protocol.
|
total antioxidant capacity will be measured in serum
|
At baseline, at 24, 48 and 192 hours following the eccentric exercise protocol.
|
|
Change in reduced glutathione in blood
Prazo: At baseline, at 24, 48 and 192 hours following the eccentric exercise protocol.
|
Concentration of oxidized glutathione will be measured in red blood cells
|
At baseline, at 24, 48 and 192 hours following the eccentric exercise protocol.
|
|
Change in thiobarbituric acid reactive substances
Prazo: At baseline, at 24, 48 and 192 hours following the eccentric exercise protocol.
|
Thiobarbituric acid will be measured in plasma
|
At baseline, at 24, 48 and 192 hours following the eccentric exercise protocol.
|
|
Change in Creatine kinase in blood
Prazo: At baseline, at 24, 48 and 192 hours following the eccentric exercise protocol.
|
Creatine kinase will be measured in plasma
|
At baseline, at 24, 48 and 192 hours following the eccentric exercise protocol.
|
|
Change in countermovement jump height
Prazo: At baseline, at 1 hour and 24, 48 and 192 hours following the eccentric exercise protocol.
|
Countermovement jump height will be measured using two force platforms at 1000 Hz, with each foot in parallel on the two platforms providing a separate yet time-synchronized measurement of the jump height data for each leg.
|
At baseline, at 1 hour and 24, 48 and 192 hours following the eccentric exercise protocol.
|
|
Change in ground reaction force (GRF) during countermovement jump test
Prazo: At baseline, at 1 hour and 24, 48 and 192 hours following the eccentric exercise protocol.
|
The ground reaction force will be measured using two force platforms at 1000 Hz, with each foot in parallel on the two platforms providing a separate yet time-synchronized measurement of the GRF data for each leg.
|
At baseline, at 1 hour and 24, 48 and 192 hours following the eccentric exercise protocol.
|
|
Change in peak power during countermovement jump test
Prazo: At baseline, at 1 hour and 24, 48 and 192 hours following the eccentric exercise protocol.
|
The peak power will be measured using two force platforms at 1000 Hz, with each foot in parallel on the two platforms providing a separate yet time-synchronized measurement of the peak power data for each leg.
|
At baseline, at 1 hour and 24, 48 and 192 hours following the eccentric exercise protocol.
|
|
Change in mean power during countermovement jump test
Prazo: At baseline, at 1 hour and 24, 48 and 192 hours following the eccentric exercise protocol.
|
The mean power will be measured using two force platforms at 1000 Hz, with each foot in parallel on the two platforms providing a separate yet time-synchronized measurement of the mean power data for each leg.
|
At baseline, at 1 hour and 24, 48 and 192 hours following the eccentric exercise protocol.
|
|
Change in vertical stifness during countermovement jump test
Prazo: At baseline, at 1 hour and 24, 48 and 192 hours following the eccentric exercise protocol.
|
The vertical stiffness will be measured using two force platforms at 1000 Hz, with each foot in parallel on the two platforms providing a separate yet time-synchronized measurement of vertical stifness data for each leg.
|
At baseline, at 1 hour and 24, 48 and 192 hours following the eccentric exercise protocol.
|
|
Change in peak rate of force develpemnt during countermovement jump test
Prazo: At baseline, at 1 hour and 24, 48 and 192 hours following the eccentric exercise protocol.
|
The Peak rate of force development will be measured using two force platforms at 1000 Hz, with each foot in parallel on the two platforms providing a separate yet time-synchronized measurement of the Peak RFD data for each leg.
|
At baseline, at 1 hour and 24, 48 and 192 hours following the eccentric exercise protocol.
|
|
Change in peak normalized EMG during the eccentric and concentric phases of the counter movement jump
Prazo: At baseline, at 1 hour and 24, 48 and 192 hours following the eccentric exercise protocol.
|
Electromyography data will be collected wirelessly at 2.000 Hz using a Myon MA-320 EMG system (Myon AG, Schwarzenberg, Switzerland) for the vastus medialis (VM) and vastus lateralis muscles.
|
At baseline, at 1 hour and 24, 48 and 192 hours following the eccentric exercise protocol.
|
|
Change in mean normalized EMG during the eccentric and concentric phases of the counter movement jump
Prazo: At baseline, at 1 hour and 24, 48 and 192 hours following the eccentric exercise protocol.
|
Electromyography data will be collected wirelessly at 2.000 Hz using a Myon MA-320 EMG system (Myon AG, Schwarzenberg, Switzerland) for the vastus medialis (VM) and vastus lateralis muscles.
|
At baseline, at 1 hour and 24, 48 and 192 hours following the eccentric exercise protocol.
|
|
Change in knee range of motion
Prazo: At baseline, at 1 hour and 24, 48 and 192 hours following the eccentric exercise protocol.
|
Knee range of motion will be measured by goniometer
|
At baseline, at 1 hour and 24, 48 and 192 hours following the eccentric exercise protocol.
|
|
Change in eccentric isokinetic knee extensors peak torque
Prazo: At baseline, 1 hour, at 24, 48 and 192 hours following the eccentric exercise protocol.
|
Eccentric isokinetic knee extensors peak torque will be assessed on an isokinetic dynamometer
|
At baseline, 1 hour, at 24, 48 and 192 hours following the eccentric exercise protocol.
|
|
Change in concentric isokinetic knee extensors peak torque
Prazo: At baseline, 1 hour, at 24, 48 and 192 hours following the eccentric exercise protocol.
|
Concentric isokinetic knee extensors peak torque will be assessed on an isokinetic dynamometer
|
At baseline, 1 hour, at 24, 48 and 192 hours following the eccentric exercise protocol.
|
|
Change in eccentric isokinetic knee flexors peak torque
Prazo: At baseline, 1 hour, at 24, 48 and 192 hours following the eccentric exercise protocol.
|
Eccentric isokinetic knee flexors peak torque will be assessed on an isokinetic dynamometer
|
At baseline, 1 hour, at 24, 48 and 192 hours following the eccentric exercise protocol.
|
|
Change in concentric isokinetic knee flexors peak torque
Prazo: At baseline, 1 hour, at 24, 48 and 192 hours following the eccentric exercise protocol.
|
Concentric Iisokinetic knee flexors peak torque will be assessed on an isokinetic dynamometer
|
At baseline, 1 hour, at 24, 48 and 192 hours following the eccentric exercise protocol.
|
|
Change in isometric peak torque
Prazo: At baseline, 1 hour, at 24, 48 and 192 hours following the eccentric exercise protocol.
|
The isometric peak torque will be assessed on an isokinetic dyanmometer
|
At baseline, 1 hour, at 24, 48 and 192 hours following the eccentric exercise protocol.
|
|
Change in fatigue index of isometric torque during 10 second
Prazo: At baseline, 1hour, at 24, 48 and 192 hours following the eccentric exercise protocol.
|
Fatigue rate during MVIC will be estimated through the percent drop of peak torque between the first and the last three seconds of a 10-secong maximal isometric contraction.
|
At baseline, 1hour, at 24, 48 and 192 hours following the eccentric exercise protocol.
|
|
Change in delayed onset of muscle soreness (DOMS) in the knee flexors (KF) and extensors (KE) of both limbs
Prazo: At baseline, 1 hour, at 24, 48 and 192 hours following the eccentric exercise protocol.
|
Muscle soreness (KF and KE) will be assessed during palpation of the muscle belly and the distal region
|
At baseline, 1 hour, at 24, 48 and 192 hours following the eccentric exercise protocol.
|
Medidas de resultados secundários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Peso corporal
Prazo: Na linha de base
|
O peso corporal será medido em uma balança de trave com estadiômetro
|
Na linha de base
|
|
Altura
Prazo: Na linha de base
|
A altura corporal será medida em uma balança de trave com estadiômetro
|
Na linha de base
|
|
Corpo gordo
Prazo: Na linha de base
|
A gordura corporal será medida usando absorciometria de raios X de dupla emissão
|
Na linha de base
|
|
Dietary intake
Prazo: Over a 5 -day period at baseline
|
Dietary intake will be assessed using 5 -day diet recalls
|
Over a 5 -day period at baseline
|
|
Consumo máximo de oxigênio (VO2max)
Prazo: Na linha de base
|
O consumo máximo de oxigênio será medido por espirometria de circuito aberto através do método respiração por respiração
|
Na linha de base
|
Colaboradores e Investigadores
Patrocinador
Datas de registro do estudo
Datas Principais do Estudo
Início do estudo (Real)
Conclusão Primária (Real)
Conclusão do estudo (Real)
Datas de inscrição no estudo
Enviado pela primeira vez
Enviado pela primeira vez que atendeu aos critérios de CQ
Primeira postagem (Real)
Atualizações de registro de estudo
Última Atualização Postada (Real)
Última atualização enviada que atendeu aos critérios de controle de qualidade
Última verificação
Mais Informações
Termos relacionados a este estudo
Palavras-chave
Outros números de identificação do estudo
- Recovery-Eccentrics-UTH
Informações sobre medicamentos e dispositivos, documentos de estudo
Estuda um medicamento regulamentado pela FDA dos EUA
Estuda um produto de dispositivo regulamentado pela FDA dos EUA
Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .